Records 1 - 26
| Clinical and CT patterns to predict EGFR mutation in patients with non-small cell lung cancer: A systematic literature review and meta-analysis.
European journal of radiology open 2022 2 9 100400.
Ortiz Andrés Felipe Herrera, Camacho Tatiana Cadavid, Vásquez Andrés Francisco, Del Castillo Herazo Valeria, Neira Juan Guillermo Arámbula, Yepes María Mónica, Camacho Eduard Cadav
| Association between the combined effects of GSTM1 present/null and CYP1A1 MspI polymorphisms with lung cancer risk: an updated meta-analysis.
Bioscience reports 2020 Sep .
Zhang Wen-Ping, He Xiao-Feng, Ye Xiang-H
| Association of MDM2 gene SNP 309 polymorphism and human non-small cell lung cancer susceptibility: A meta-analysis.
Pathology, research and practice 2019 Jul 152538.
Luan Lan, Wang Hongying, Zhao Beibei, Wang Fan, Shi Juan, Xu Xiaj
| CT and clinical characteristics that predict risk of EGFR mutation in non-small cell lung cancer: a systematic review and meta-analysis.
International journal of clinical oncology 2019 Mar .
Zhang Hanfei, Cai Weiguo, Wang Yanfan, Liao Meiyan, Tian Sufa
| ATM rs189037 (G?>?A) polymorphism increased the risk of cancer: an updated meta-analysis.
BMC medical genetics 2019 Feb 20 (1): 28.
Zhao Zhi-Liang, Xia Lu, Zhao Cong, Yao J
| Association between PD-L1 expression and driver gene status in non-small-cell lung cancer: a meta-analysis.
Oncotarget 2018 Jan 9 (7): 7684-7699.
Lan Bo, Ma Chengxi, Zhang Chengyan, Chai Shoujie, Wang Pingli, Ding Liren, Wang K
| Prognostic value of MET copy number gain in non-small-cell lung cancer: an updated meta-analysis.
Journal of Cancer 2018 9 (10): 1836-1845.
Kim Jung Han, Kim Hyeong Su, Kim Bum J
| Evaluation of Prediction of Polymorphisms of DNA Repair Genes on the Efficacy of Platinum-Based Chemotherapy in Patients With Non-Small Cell Lung Cancer: A Network Meta-Analysis.
Journal of cellular biochemistry 2017 12 118 (12): 4782-4791.
Yu Shao-Nan, Liu Gui-Feng, Li Xue-Feng, Fu Bao-Hong, Dong Li-Xin, Zhang Shu-H
| KRAS mutation is a weak, but valid predictor for poor prognosis and treatment outcomes in NSCLC: A meta-analysis of 41 studies.
Oncotarget 2016 Jan .
Pan Wei, Yang Yan, Zhu Hongcheng, Zhang Youcheng, Zhou Rongping, Sun Xinch
| Association between the TERT Genetic Polymorphism rs2853676 and Cancer Risk: Meta-Analysis of 76,108 Cases and 134,215 Controls.
PloS one 2015 10 (6): e0128829.
Cao Jin-Lin, Yuan Ping, Abuduwufuer Abudumailamu, Lv Wang, Yang Yun-Hai, Hu Ji
| Meta analysis of XRCC3 Thr241Met polymorphism and lung cancer susceptibility of populations in East Asia.
Asian Pacific journal of tropical medicine 2014 Jun 7 (6): 483-7.
Xing Zhi-Song, Zhu Guang, Yang Yu-Lun, Feng Guang-Qiang, Ding Guang-Che
| Role of MDM2 T309G polymorphism in susceptibility and prognosis of nonsmall cell lung cancer: a meta-analysis.
Genetic testing and molecular biomarkers 2014 May 18 (5): 357-65.
Kong Qian, Li Ping, Tian Qiong, Ha Min-W
| Association between Catechol-O-methyltransferase rs4680 (G>A) polymorphism and lung cancer risk.
Diagnostic pathology 2014 9 192.
Tan Xiang, Chen Ming
| Association between HIF-1a C1772T/G1790A polymorphisms and cancer susceptibility: an updated systematic review and meta-analysis based on 40 case-control studies.
BMC cancer 2014 14 950.
Yan Qing, Chen Pin, Wang Songtao, Liu Ning, Zhao Peng, Gu Aih
| Diagnostic value of mutation-specific antibodies for immunohistochemical detection of epidermal growth factor receptor mutations in non-small cell lung cancer: a meta-analysis.
PloS one 2014 9 (9): e105940.
Chen Zi, Liu Hong-bing, Yu Chun-hua, Wang Ying, Wang Li, Song Yo
| MET gene copy number predicts worse overall survival in patients with non-small cell lung cancer (NSCLC); a systematic review and meta-analysis.
PloS one 2014 9 (9): e107677.
Dimou Anastasios, Non Lemuel, Chae Young Kwang, Tester William J, Syrigos Konstantinos
| Prognostic value of MET gene copy number and protein expression in patients with surgically resected non-small cell lung cancer: a meta-analysis of published literatures.
PloS one 2014 9 (6): e99399.
Guo Baoping, Cen Hong, Tan Xiaohong, Liu Wenjian, Ke Qi
| Sequential treatment of tyrosine kinase inhibitors and chemotherapy for EGFR-mutated non-small cell lung cancer: a meta-analysis of Phase III trials.
OncoTargets and therapy 2013 1771-7.
Zhang Yiliang, Sun Yihua, Wang Lei, Ye Ting, Pan Yunjian, Hu Haichuan, Yu Yongfu, Zhao Naiqing, Song Yanyan, Garfield David, Chen Haiqu
| Erlotinib in wild type epidermal growth factor receptor non-small cell lung cancer: A systematic review.
Annals of thoracic medicine 2013 Oct 8 (4): 204-8.
Jazieh Abdul-Rahman, Al Sudairy Reem, Abu-Shraie Nada, Al Suwairi Wafaa, Ferwana Mazen, Murad M Hass
| Cytochrome P450 2A6 deletion polymorphism and risk of lung cancer: a meta-analysis.
Molecular biology reports 2013 Sep 40 (9): 5255-9.
Liu Zheng-Bing, Shu Jun, Wang Li-Ping, Jin Cheng, Lou Zhi-X
| Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation.
Health technology assessment (Winchester, England) 2013 Jul 17 (31): 1-278.
Brown T, Pilkington G, Bagust A, Boland A, Oyee J, Tudur-Smith C, Blundell M, Lai M, Martin Saborido C, Greenhalgh J, Dundar Y, Dickson
| No significant association between the XRCC3 Thr241Met polymorphism and lung cancer risk: a meta-analysis.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2013 Apr 34 (2): 865-74.
Xu Yun-Hua, Gu Lin-Ping, Sun Ying-Jia, Cheng Bai-Jun, Lu Sh
| A literature-based systematic HuGE review and meta-analysis show that CASP gene family polymorphisms are associated with risk of lung cancer.
Genetics and molecular research : GMR 2013 Jan 12 (AOP): AOP.
Zhang ZY, Xuan Y, Jin XY, Tian X, Wu R
| XRCC1 Arg399Gln and clinical outcome of platinum-based treatment for advanced non-small cell lung cancer: a meta-analysis in 17 studies.
Journal of Zhejiang University. Science. B 2012 Nov 13 (11): 875-83.
Chen Jian, Zhao Qing-wei, Shi Gen-ming, Wang Lin-r
| Predictive value of XRCC1 gene polymorphisms on platinum-based chemotherapy in advanced non-small cell lung cancer patients: a systematic review and meta-analysis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012 Jul 18 (14): 3972-81.
Wu Junjie, Liu Jie, Zhou Yuhao, Ying Jun, Zou Houdong, Guo Shicheng, Wang Lei, Zhao Naiqing, Hu Jianjun, Lu Daru, Jin Li, Li Qiang, Wang Jiu-C
| XRCC3 Thr241Met polymorphism with lung cancer and bladder cancer: a meta-analysis.
Cancer science 2010 Aug 101 (8): 1777-82.
Sun Haiming, Qiao Yuandong, Zhang Xuelong, Xu Lidan, Jia Xueyuan, Sun Donglin, Shen Chao, Liu An, Zhao Yanling, Jin Yan, Yu Yang, Bai Jing, Fu Songb